AI learns to spot bladder cancer under blue light

NCT ID NCT07144319

Recruiting now Diagnosis Sponsor: Photocure Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study collects video recordings and data from 500 patients undergoing blue light cystoscopy, a procedure where a drug makes cancer cells glow. The goal is to train an artificial intelligence (AI) algorithm to detect bladder lesions in real time, helping doctors make more accurate decisions during routine exams. No new treatments are being tested—only data is being gathered to develop the AI tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hexvix/Cysview (a drug that makes cancer cells glow under blue light)
What this could lead to: If successful, this could lead to an AI tool that helps doctors spot bladder cancer more reliably during cystoscopy, potentially reducing missed lesions.
What could go wrong: This is an early data-collection study, not a treatment trial. The AI is not yet tested in real-time use, and results may not translate into immediate patient benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms superficial urinary bladder carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER NON-MUSCLE INVASIVE BLADDER CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
Oslo University Hospital
RECRUITING

Oslo, Norway
Regents of the University of Michigan
RECRUITING

Ann Arbor, Michigan, 48108, United States
Rutgers Cancer Institute
RECRUITING

New Brunswick, New Jersey, 08901, United States
UZ Leuven
RECRUITING

Leuven, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.